IBDEI0YZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15608,1,3,0)
 ;;=3^DM Type 2 w/ CKD
 ;;^UTILITY(U,$J,358.3,15608,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,15608,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,15609,0)
 ;;=E11.319^^88^864^22
 ;;^UTILITY(U,$J,358.3,15609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15609,1,3,0)
 ;;=3^DM Type 2 w/ Retinopathy Unspec w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,15609,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,15609,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,15610,0)
 ;;=G40.909^^88^864^74
 ;;^UTILITY(U,$J,358.3,15610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15610,1,3,0)
 ;;=3^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,15610,1,4,0)
 ;;=4^G40.909
 ;;^UTILITY(U,$J,358.3,15610,2)
 ;;=^5003865
 ;;^UTILITY(U,$J,358.3,15611,0)
 ;;=N52.9^^88^864^28
 ;;^UTILITY(U,$J,358.3,15611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15611,1,3,0)
 ;;=3^Erectile Dysfuntion,Unspec
 ;;^UTILITY(U,$J,358.3,15611,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,15611,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,15612,0)
 ;;=I50.22^^88^864^37
 ;;^UTILITY(U,$J,358.3,15612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15612,1,3,0)
 ;;=3^Heart Failure,Systolic,Chronic
 ;;^UTILITY(U,$J,358.3,15612,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,15612,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,15613,0)
 ;;=I50.32^^88^864^35
 ;;^UTILITY(U,$J,358.3,15613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15613,1,3,0)
 ;;=3^Heart Failure,Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,15613,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,15613,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,15614,0)
 ;;=I50.42^^88^864^36
 ;;^UTILITY(U,$J,358.3,15614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15614,1,3,0)
 ;;=3^Heart Failure,Systolic & Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,15614,1,4,0)
 ;;=4^I50.42
 ;;^UTILITY(U,$J,358.3,15614,2)
 ;;=^5007249
 ;;^UTILITY(U,$J,358.3,15615,0)
 ;;=I13.0^^88^864^30
 ;;^UTILITY(U,$J,358.3,15615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15615,1,3,0)
 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,15615,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,15615,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,15616,0)
 ;;=I13.2^^88^864^31
 ;;^UTILITY(U,$J,358.3,15616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15616,1,3,0)
 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,15616,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,15616,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,15617,0)
 ;;=I13.10^^88^864^32
 ;;^UTILITY(U,$J,358.3,15617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15617,1,3,0)
 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,15617,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,15617,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,15618,0)
 ;;=I13.11^^88^864^33
 ;;^UTILITY(U,$J,358.3,15618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15618,1,3,0)
 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,15618,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,15618,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,15619,0)
 ;;=E03.9^^88^864^43
 ;;^UTILITY(U,$J,358.3,15619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15619,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,15619,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,15619,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,15620,0)
 ;;=M54.5^^88^864^46
 ;;^UTILITY(U,$J,358.3,15620,1,0)
 ;;=^358.31IA^4^2
